Method of reversing immune suppression of Langerhans cells

Details for Australian Patent Application No. 2010328197 (hide)

Owner Da Silva, D. IRx Therapeutics, Inc. Brandwein, H. Egan, J. Kast, M.

Inventors Egan, James; Kast, Martin; Da Silva, Diane; Brandwein, Harvey

Agent Lord & Company

Pub. Number AU-A-2010328197

PCT Pub. Number WO2011/072006

Priority 61/267,590 08.12.09 US

Filing date 8 December 2010

Wipo publication date 16 June 2011

International Classifications

C12P 21/04 Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

26 July 2012 PCT application entered the National Phase

  PCT publication WO2011/072006 Priority application(s): WO2011/072006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010328203-Improved methods and compositions for vein harvest and autografting

2010328194-Wooden pallet with nail plates and related methods